Healthleap raises $38M to flag hidden risks buried in patient records

South African startup Healthleap has closed $38 million in funding to expand a platform that scans hospital records for undiagnosed risks such as malnutrition and delirium. The company, founded in 2022 by siblings Jemima and Josiah Meyer, began as a clinical nutrition tool Jemima built for dietitians before pivoting to a broader system that ingests both free-text clinical notes and structured data — labs, vitals, medications, diet orders — to surface patients who might otherwise be missed.

Sequoia Capital and First Round Capital co-led an $8 million seed round; Hummingbird Ventures led the $30 million Series A. The company does not disclose its valuation.

The technical engine connects large language models to a hospital's electronic health record (EHR). Each night it runs the pipeline on every adult inpatient, extracting mentions of weight loss, swallowing difficulty and similar signals from clinicians' notes, cross-referencing them with structured data, and writing a risk score back into the existing clinical workflow by morning, alongside a dashboard that tracks trends. Chief executive Josiah Meyer emphasizes the software does not diagnose; it only flags patients for further review.

The platform is now deployed in more than 50 hospitals screening for malnutrition and delirium. Additional modules for aspiration pneumonia, pressure ulcers and heart-failure readmission risk remain in clinical validation. The clinical rationale is well established: studies indicate 20% to 50% of inpatients suffer from malnutrition, which is associated with longer stays, poor wound healing, infections and higher mortality. Meyer says the company grew from three partner hospitals to over 50 in the past year, counting Penn Medicine, Cedars-Sinai, Intermountain, Houston Methodist and Emory Healthcare among them. Revenue increased more than 10x in the same period; absolute figures were not disclosed.

Contracts run three years and are priced per licensed bed with an outcome-based component: the hospital verifies the hard ROI attributed to the product, and Healthleap contractually commits to delivering multiples of the contract price. Meyer claims every customer has seen at least a 5x return, with some exceeding 20x annually. At the University of Pennsylvania hospital, the malnutrition program reportedly generated $23.8 million in annual financial impact — $6.3 million from additional reimbursements and $17.5 million from reduced length of stay. The source did not publish a full methodology breakdown.

What remains absent from the picture are independently audited ROI figures, standard model-performance metrics such as sensitivity and specificity, and disclosure of which language models run in production. Because the new modules are still undergoing clinical validation, the proven value today is limited to malnutrition and delirium; the rest is potential.